Patent US3943246A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3943246A Expired / Lapsed US ⏱️ 0.0 years remaining

Organic compounds

Assignee: Sandoz AG
•
Filing: 1974-08-28
•
Granted: 1976-03-09
•
Expires: 1994-08-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This invention concerns a novel use of oxytocin and desamino-oxytocin for treating impotency in the human male.

Inventors

  • 👤 Egon Sturmer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 23:03
CPC Classifications
A; A61; A61K; A61K38/00; A61K38/04; A61K38/08; A61K38/095

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 27 words
A method of treating impotency in a human male in need of said treatment which comprises administering oxytocin at a dosage of 300 to 1500 I.U. daily.
Claim 2
Independent Claim 27 words
A method of treating impotency in a human male in need of said treatment which comprises administering oxytocin at a dosage of 300 to 1500 I.U. daily.
Claim 3
Dependent Claim 25 words
A method according to claim 1, in which oxytocin is administered in unit dosage form containing from about 50 to about 500 I.U. of oxytocin.
Claim 4
Dependent Claim 18 words
A method according to claim 2, in which the unit dosage form is a buccal or peroral tablet.
Claim 5
Independent Claim 27 words
A method of treating impotency in a human male in need of said treatment which comprises administering desamino-oxytocin at a dosage of 150 to 750 I.U. daily.
Claim 6
Independent Claim 27 words
A method of treating impotency in a human male in need of said treatment which comprises administering desamino-oxytocin at a dosage of 150 to 750 I.U. daily.
Claim 7
Dependent Claim 26 words
A method according to claim 4, in which the desamino-oxytocin is administered in unit dosage form containing from about 25 to about 250 I.U. of desamino-oxytocin.
Claim 8
Dependent Claim 18 words
A method according to claim 5, in which the unit dosage form is a buccal or peroral tablet.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-03-09 1979-09-08 1980-03-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-03-09 1983-09-08 1984-03-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-03-09 1987-09-08 1988-03-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag